VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog
โ† Value Add PulseFUNDING$510B H1 2026 (record)

Global Startup Funding Hit a Record $510B in H1 2026 as AI Concentration Deepens

Global venture funding hit $510 billion in the first half of 2026, Crunchbase News reported July 2 -- surpassing all of 2025's $440 billion total in just six months -- with OpenAI and Anthropic alone accounting for $217 billion (43%) of the total, and AI-focused companies capturing over 70% of Q2 global capital, up from roughly 50% a year earlier.

$510B (record)
H1 2026 Global Funding
$440B
Full-Year 2025 Total
$305B (largest quarter on record)
Q1 2026
$205B across 5,000+ startups
Q2 2026
$217B (43% of H1)
OpenAI + Anthropic Share
TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
July 2, 2026
2 min read
ShareXLinkedInEmail
KEY TAKEAWAYS FOR VCs & FOUNDERS
1

A half-year record that already exceeds all of the prior full year is an unambiguous signal that 2026 is a genuine capital supercycle, not just elevated deal flow

2

Two companies (OpenAI, Anthropic) absorbing 43% of six months of global venture funding is an extraordinary concentration level, with real implications for diversification at the fund level

3

AI's share of quarterly capital jumping from roughly 50% to over 70% year-over-year in a single year shows the concentration is accelerating, not plateauing

4

US share of Q2 funding fell from 83% to 66-67%, showing capital is internationalizing even as it concentrates by sector

TC
The VC Read ยท Trace's TakeTrace Cohen

A half-year number that already beats the entire prior full year is the kind of headline that's easy to skim past, but sit with it for a second: global venture capital deployed more in six months of 2026 than in all twelve months of 2025, and that's before accounting for whatever H2 brings. The 43% concentration in just OpenAI and Anthropic is the number that actually matters for portfolio construction -- if you're an LP without direct or adjacent exposure to those two names, your fund's AI exposure story looks very different than the headline sector allocation suggests. The US share of funding dropping from 83% to 66-67% in a single quarter is the quieter, more interesting trend -- capital is internationalizing even as it concentrates by sector, which is a genuinely unusual combination. For founders outside the absolute frontier of model development, more total capital is available than ever, but a shrinking share of it is realistically available to you if you're not adjacent to the two companies soaking up nearly half the market. Watch whether H2 sustains this pace or whether the concentration in OpenAI and Anthropic specifically starts to normalize as competing labs and infrastructure players fight for the same dollars.

๐Ÿ’ฐ VC Fundraises 2026 โ†’๐Ÿ“ˆ AI Valuations โ†’

Global venture funding reached $510 billion in the first half of 2026, Crunchbase News reported July 2, 2026 -- a record for any half-year period that already surpasses the entire $440 billion raised across all of 2025, and well past the prior half-year record of $375 billion set in the second half of 2021. The scale of the number is best understood quarter by quarter: Q1 2026 alone hit $305 billion, the largest quarter on record, followed by $205 billion across more than 5,000 startups in Q2.

The concentration behind those totals is the more striking part of the report. OpenAI and Anthropic combined accounted for $217 billion, or 43%, of the entire first half's global funding -- meaning two companies absorbed nearly half of all venture capital deployed worldwide across six months. More broadly, AI-focused companies captured over 70% of global capital in Q2 alone, up sharply from roughly 50% a year earlier, showing the sector's share of overall venture funding is still accelerating rather than leveling off even as the AI investment cycle enters its third year.

Geographically, the picture is shifting in a way that complicates the concentration narrative: US-based companies accounted for 66-67% of Q2 funding, down meaningfully from 83% in Q1 -- suggesting that even as capital concentrates heavily by sector (AI), it's simultaneously internationalizing by geography, with non-US AI and adjacent companies capturing a larger relative share than earlier in the year.

โ€œThe concentration behind those totals is the more striking part of the report.โ€

The funding-by-stage breakdown reinforces how broadly the boom is being felt across the venture lifecycle: late-stage funding reached $134 billion, up 141% year-over-year, while early-stage funding was up more than 100% year-over-year as well. Exit activity told a similarly record-breaking story in the same period -- 32 companies went public above a $1 billion valuation in Q2 alone, and 24 more were acquired at $1 billion-plus valuations totaling $113 billion, a record quarter for large-scale M&A.

For GPs and LPs, a half-year figure that already exceeds all of the prior full year is the clearest possible evidence that 2026 represents a genuine step-change in venture capital deployment, not simply continued growth along a prior trendline. But the extraordinary concentration in just two companies -- OpenAI and Anthropic together absorbing 43% of six months of global funding -- raises real portfolio-construction questions for any fund not directly exposed to those two names or their closest ecosystem partners.

For founders outside the absolute frontier of AI model development, the data is a double-edged signal: overall capital availability has never been higher, but an increasing share of it is being drawn toward a small number of the largest, most capital-intensive companies in the industry, potentially at the expense of capital available to earlier-stage or non-AI-native startups competing for the same generalist LP dollars.

What to watch: whether H2 2026 sustains or exceeds H1's pace, whether the OpenAI/Anthropic concentration level continues rising or begins to normalize as more frontier labs and infrastructure players compete for the same capital, and whether the shift toward non-US funding share in Q2 continues as a durable trend into the second half of the year.

ShareXLinkedInEmail
More onAnthropic โ†’OpenAI โ†’

Originally reported by Crunchbase News. Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse

Read Next

FUNDINGNew firm targets AI infra, energy, deep tech

Ashton Kutcher Leaves Sound Ventures to Launch a New Firm With Morgan Beller

Ashton Kutcher is departing Sound Ventures, the firm he co-founded 11 years ago with Guy Oseary, to launch a new early-stage firm with Morgan Beller -- a former Andreessen Horowitz partner and NFX general partner who also co-led Meta's Libra cryptocurrency project -- targeting AI infrastructure, energy and deep tech, TechCrunch reported July 1. The new firm's name and fund size have not yet been disclosed, and Kutcher will remain an adviser to Sound Ventures while Oseary and GP Effie Epstein advise the new firm.

FUNDING$54.2M Series B

Nobel Laureate's Qolab Raises $54.2M Series B to Scale Superconducting Quantum Chips

Qolab, a Santa Barbara superconducting-quantum-processor startup co-founded by 2025 Nobel physics laureate John Martinis, closed a $54.2 million Series B led by UC Investments on July 2, with WARF, Octave Ventures and Phoenix Venture Partners also participating, to fund semiconductor fabrication partnerships and manufacturing scale-up toward fault-tolerant quantum computing.

FUNDING$180M Series B

Celea Therapeutics Raises $180M Series B for Pulmonary Fibrosis Drug

Celea Therapeutics, a clinical-stage biotech spun out of PureTech developing deupirfenidone for idiopathic pulmonary fibrosis, announced a $180 million Series B on July 2, led by RA Capital and Leaps by Bayer, with PureTech and additional unnamed health-focused and sovereign funds participating, per weekly funding roundups covering the deal.

@Trace_Cohenยทt@nyvp.com